Sponsor pipeline

LMC Diabetes & Endocrinology Ltd. clinical trial pipeline

Get alerts when LMC Diabetes & Endocrinology Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor

    Completed without a posted recruiting period

    Also in this update: Final enrollment: 3392 participants (planned 400); Primary completion date changed from estimate of Apr 2026 to Sep 28, 2026

    LMC Diabetes & Endocrinology Ltd.Not specified NCT07424430 Registry history

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Not charted: 3 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials

Diabetes (3) · Type 2 Diabetes (3)

Get alerts when LMC Diabetes & Endocrinology Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free